---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-061872"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T16:48:16.184931+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics stockholders re-elect two Class III directors; ratify KPMG as auditor

## Summary
- Andrew Cheng re-elected with 27.4M votes for, 13.0M withheld; Scott Morrison with 31.6M for, 8.8M withheld.
- Broker non-votes were 1,020,833 for both director elections.
- KPMG ratified as independent auditor for FY2024: 41.4M for, 1,832 against, 7,116 abstain.
- Meeting held May 15, 2024; 54,451,375 Class A shares outstanding as of record date March 18.

## SEC filing metadata
- accession: 0000950170-24-061872
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/0000950170-24-061872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/vera-20240515.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-061872
- JSON: https://secwatch.observer/filing/0000950170-24-061872.json
- Plain text: https://secwatch.observer/filing/0000950170-24-061872.txt

## Source-grounded claims
- claim_id: 5d22a4daf5dd0aaf5f568a2cc316756eb223df2d
  claim: Vera Therapeutics, Inc. shareholders approved Ratification of the Selection of KPMG LLP as the independent registered public accounting firm at the 2024-05-15 meeting.
  evidence_excerpt: Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/0000950170-24-061872-index.htm
- claim_id: 5db620deafe23c1d764118a5ce5bffd81bfe7cfc
  claim: Vera Therapeutics, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.
  evidence_excerpt: Proposal 1. Election of Directors The Company’s stockholders elected the three persons listed below as Class III Directors, each to serve until the Company’s 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831828/000095017024061872/0000950170-24-061872-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.